Results 161 to 170 of about 112,643 (334)
Automated radiotherapy planning for volumetric modulated arc therapy in lung cancer
Abstract Background Volumetric‐modulated arc therapy (VMAT) treatment planning balances the need for adequate coverage of the planning target volume (PTV) and the sparing of organs‐at‐risk (OARs). However, this time‐consuming iterative process is influenced by the planner's experience, personal preferences, and the time devoted to create the plan. This
Johann Brand +9 more
wiley +1 more source
Clinical Characteristics of Parkinsonism in HTLV‐1‐Associated Myelopathy
ABSTRACT Objective Human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the classic neurological manifestation of HTLV‐1 infection; however, this virus has also been associated with other neurological disorders. Concurrent parkinsonism is relatively rare and presents diagnostic challenges.
Mika Dozono +8 more
wiley +1 more source
Primary Seminoma of the Anterior Mediastinum
Ali A. El‐Domeiri +3 more
openalex +1 more source
Alpha-1-fetoprotein in a patient with a poorly differentiated carcinoma of the anterior mediastinum [PDF]
H. Terry Wepsic +2 more
openalex +1 more source
Tracheoesophageal fistula (TEF), a pathological trachea‐esophagus connection, arises congenitally or from malignancy/radiotherapy/trauma, causing aspiration and malnutrition. Diagnosis utilizes imaging and endoscopy. Treatment ranges from endoscopic stenting to surgical repair and conservative management.
Gang Li +10 more
wiley +1 more source
Mediastinal lymphangioma and generalized lymphangiomatosis a case report
Jusufovic Edin, Keser Dragan, Zukic Edin
doaj +1 more source
A case report of radiation therapy of seminoma metastasised to the retroperitoneum and mediastinum [PDF]
HS Yoo, BS Choi, Dong Hoon Lee
openalex +1 more source
ABSTRACT Tuberous sclerosis complex (TSC) is a rare and complex autosomal dominant disease. Many patients with TSC may remain undiagnosed for years due to its widespread and heterogeneous clinical presentation, with only 1% of TSC patients developing end‐stage renal disease (ESRD).
Changlin Wei +5 more
wiley +1 more source

